News from beactica ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 18, 2019, 02:16 ET Beactica Wins Grant to Develop Combination Therapy for Glioblastoma

Beactica AB, the Swedish drug discovery company, today announced that it has been awarded a grant of 2.8 MSEK (~$300 000) from SweLife and...


Jun 04, 2019, 02:27 ET Beactica Secures Another Round of Financing as Novel Glioblastoma Treatment Advances Towards Pre-clinical Development

Beactica AB, the Swedish drug discovery company, today announced the completion of a new financing round that will enable the company to take its...


Mar 12, 2019, 03:16 ET Dong-A ST and Beactica Expand Their Research and Licence Agreement to Develop New Cancer Treatments

Dong-A ST Co., Ltd. (170900: Korea SE), the Korean pharmaceutical company, and Beactica AB, the Swedish drug discovery company, today announced an...


Aug 28, 2018, 02:32 ET Beactica Closes Financing Round to Accelerate its Pipeline of Novel Cancer Therapeutics

Beactica, the Swedish drug discovery company, today announced the completion of its latest financing round, providing significant funds that will be...


May 27, 2018, 06:43 ET Beactica Signs Three-Year Extension Agreement With Sanofi

Beactica, the Swedish drug discovery company with world-leading expertise in molecular interactions, today announced that it has signed a three-year...


May 26, 2015, 09:00 ET Beactica Scientists Publish Strategies for Discovery of Allosteric Modulators

Beactica, the Swedish fragment-based drug discovery company, today announced the publication of a key paper in Proceedings of the National Academy of ...


Nov 20, 2014, 09:00 ET Beactica Awarded Funding to Develop Epigenetic Cancer Drugs

Beactica, the Swedish fragment-based drug discovery company, today announced that it has been awarded a SEK 3.0 million grant from the Swedish...


Oct 22, 2013, 08:00 ET Beactica Expands its Drug Discovery Collaboration with Boehringer Ingelheim

Beactica today announced that it has expanded its collaboration with Boehringer Ingelheim. For the additional project, Beactica will use its...


Oct 29, 2012, 09:00 ET Beactica Contributes to Detailed Understanding of Innovative Cancer Drug

Beactica, the Swedish drug discovery company with world-leading expertise in molecular interactions, today announced its contribution to a key paper...


Dec 06, 2011, 09:00 ET Beactica and Almac Discovery Announce Their First Fragment-Based Drug Discovery Agreement

Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Almac Discovery Ltd., ...


Dec 06, 2011, 04:00 ET Beactica startar samarbete med Almac Discovery

Beactica AB, det Uppsala-baserade läkemedelsforskningsföretaget, meddelar idag att ett samarbetsavtal har slutits med irländska Almac Discovery Ltd,...


Apr 27, 2011, 09:00 ET Beactica Announces Fragment-Based Drug Discovery Agreement

Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Janssen Research &...